Monsanto, Bayer CropScience end dispute
February 10, 2005
The Associated Press reports that agribusiness giant Monsanto Co. has resolved a patent dispute with Bayer CropScience and a German non-profit research organization, and those involved will cross-license some technologies worldwide, the companies said last week. The announcement ends a long-standing rift over agrobacterium technology, a process that allows scientists to transfer DNA to plant cells. Financial terms of the settlement were not disclosed. Bayer CropScience is the exclusive licensee for the Max Planck Society for the Advancement of Science. Both are based in Germany. Under the agreement, Bayer CropScience and St. Louis-based Monsanto will cross-license the agrobacterium-mediated transformation in selected areas of the globe. Also, Monsanto will provide the Max Planck Society with a research license in the U.S.